Evaluation of ROTARIX
Africa
ROTARIX®
Zambia
booster dose
immunogenicity
rotavirus
safety
vaccine
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
03 Feb 2023
03 Feb 2023
Historique:
received:
09
11
2022
revised:
15
12
2022
accepted:
30
01
2023
entrez:
28
2
2023
pubmed:
1
3
2023
medline:
1
3
2023
Statut:
epublish
Résumé
Oral rotavirus vaccines show diminished immunogenicity in low-resource settings where rotavirus burden is highest. This study assessed the safety and immune boosting effect of a third dose of oral ROTARIX
Identifiants
pubmed: 36851224
pii: vaccines11020346
doi: 10.3390/vaccines11020346
pmc: PMC9960729
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European & Developing Countries Clinical Trials Partnership
ID : TMA2016SF-1511
Organisme : Wellcome Trust
ID : 211356/Z/18/Z
Pays : United Kingdom
Références
Lancet Infect Dis. 2018 Nov;18(11):1211-1228
pubmed: 30243583
PLoS One. 2016 Mar 14;11(3):e0150100
pubmed: 26974432
Lancet Glob Health. 2019 Nov;7(11):e1472-e1473
pubmed: 31607450
Vaccine. 2021 Jun 16;39(27):3633-3640
pubmed: 33992437
J Infect Dis. 2018 Jul 13;218(4):606-613
pubmed: 29659924
Clin Infect Dis. 2018 Jul 2;67(2):186-192
pubmed: 29394355
J Infect Dis. 2016 Jun 1;213(11):1686-93
pubmed: 26823338
PLoS Med. 2012;9(10):e1001330
pubmed: 23109915
J Infect Dis. 2020 Oct 13;222(10):1731-1739
pubmed: 32095831
J Infect Dis. 2004 Jun 15;189(12):2290-3
pubmed: 15181577
Lancet Glob Health. 2019 May;7(5):e568-e584
pubmed: 31000128
BMC Infect Dis. 2012 Sep 13;12:213
pubmed: 22974466
Cochrane Database Syst Rev. 2021 Nov 17;11:CD008521
pubmed: 34788488
Hum Vaccin Immunother. 2021 Jun 3;17(6):1787-1802
pubmed: 33327868
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Vaccine. 2017 Dec 18;35(51):7198-7203
pubmed: 29169893
Clin Infect Dis. 2016 May 1;62 Suppl 2:S183-7
pubmed: 27059354